| RS267606887 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS267606888 |
MT-ND2
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, Mitochondrial disease |
| RS267606890 |
MT-ND3
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, mitochondrial type 1 |
| RS267606891 |
MT-ND3
|
Health Risk |
Pathogenic |
Leber optic atrophy and dystonia, Mitochondrial complex I deficiency |
| RS267606893 |
MT-ND5
|
Health Risk |
Likely pathogenic |
Leigh syndrome due to mitochondrial complex I deficiency, Leigh syndrome |
| RS267606897 |
MT-ND5
|
Health Risk |
Pathogenic |
Leigh syndrome due to mitochondrial complex I deficiency, MELAS syndrome |
| RS267606898 |
MT-ND5
|
Health Risk |
Likely pathogenic |
MELAS syndrome, MERRF syndrome |
| RS267606900 |
MTPAP
|
Health Risk |
Pathogenic |
Spastic ataxia 4, Spastic ataxia 4 |
| RS267606902 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS267606903 |
MYH6
|
Health Risk |
Pathogenic |
Atrial septal defect 3, Atrial septal defect 3 |
| RS267606904 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 14, Hypertrophic cardiomyopathy |
| RS267606906 |
MYH6
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1EE, Dilated cardiomyopathy 1EE |
| RS267606908 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS267606909 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 5, Cardiomyopathy |
| RS267606911 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS267606913 |
NDUFS6
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS267606914 |
NKX2-6
|
Health Risk |
Likely pathogenic |
Persistent truncus arteriosus, Conotruncal heart malformations |
| RS267606915 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS267606916 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis 3, Nephronophthisis |
| RS267606917 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS267606918 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS267606919 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Nephrotic syndrome |
| RS267606920 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 6, Noonan syndrome 1 |
| RS267606921 |
NRAS
|
Health Risk |
Pathogenic |
Noonan syndrome 6, Noonan syndrome 1 |
| RS267606922 |
NRXN1
|
Health Risk |
Pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS267606923 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS267606924 |
OAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS267606925 |
OAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS267606926 |
OCLN
|
Health Risk |
Pathogenic |
Pseudo-TORCH syndrome 1, Pseudo-TORCH syndrome 1 |
| RS267606927 |
OPN1MW
|
Health Risk |
Pathogenic |
Cone dystrophy 5, X-linked |
| RS267606928 |
OPTN
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS267606929 |
OPTN
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS267606931 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome |
| RS267606932 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1F |
| RS267606933 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS267606934 |
PDE6C
|
Health Risk |
Pathogenic |
Achromatopsia 5, Achromatopsia 5 |
| RS267606935 |
PDE6C
|
Health Risk |
Pathogenic |
Achromatopsia 5, Achromatopsia 5 |
| RS267606936 |
PDE6C
|
Health Risk |
Pathogenic |
Achromatopsia 5, Achromatopsia 5 |
| RS267606937 |
PDE6C
|
Health Risk |
Pathogenic |
Achromatopsia 5, Achromatopsia 5 |
| RS267606938 |
PDP1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase phosphatase deficiency, Pyruvate dehydrogenase phosphatase deficiency |
| RS267606939 |
PDYN
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 23, Spinocerebellar ataxia type 23 |
| RS267606941 |
PDYN
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 23, Spinocerebellar ataxia type 23 |
| RS267606943 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS267606944 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS267606945 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS267606946 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS267606947 |
PHGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS267606948 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS267606949 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS267606950 |
SERPINA1
|
Health Risk |
Pathogenic |
Alpha-1-antitrypsin deficiency, PI Q0(GRANITE FALLS) |
| RS267606951 |
PIGV
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 1, Hyperphosphatasia with intellectual disability syndrome 1 |
| RS267606952 |
PIGV
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 1, Hyperphosphatasia with intellectual disability syndrome 1 |
| RS267606953 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS267606954 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS267606955 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS267606956 |
PNKP
|
Health Risk |
Pathogenic |
Microcephaly, seizures |
| RS267606957 |
PNKP
|
Health Risk |
Pathogenic |
Microcephaly, seizures |
| RS267606958 |
PNPO
|
Health Risk |
Pathogenic |
Pyridoxal phosphate-responsive seizures, Pyridoxal phosphate-responsive seizures |
| RS267606959 |
POLG
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 4b, Progressive sclerosing poliodystrophy |
| RS267606960 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS267606961 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS267606962 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS267606963 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS267606964 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS267606965 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS267606966 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS267606969 |
POMT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS267606970 |
POMT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS267606971 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS267606973 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Anophthalmia-microphthalmia syndrome |
| RS267606974 |
POU3F4
|
Health Risk |
Pathogenic |
X-linked mixed hearing loss with perilymphatic gusher, X-linked mixed hearing loss with perilymphatic gusher |
| RS267606976 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 6, Cardiomyopathy |
| RS267606977 |
PRKAG2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 6, Lethal congenital glycogen storage disease of heart |
| RS267606978 |
PRKAG2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 6, Hypertrophic cardiomyopathy |
| RS267606979 |
PRKAG2
|
Health Risk |
Likely pathogenic |
Lethal congenital glycogen storage disease of heart, Lethal congenital glycogen storage disease of heart |
| RS267606981 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS267606982 |
PRSS1
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS267606983 |
PSEN1
|
Health Risk |
Likely pathogenic |
Alzheimer disease, familial |
| RS267606984 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 1 |
| RS267606985 |
PTHLH
|
Health Risk |
Pathogenic |
Brachydactyly type E2, Brachydactyly type E2 |
| RS267606986 |
PTHLH
|
Health Risk |
Pathogenic |
Brachydactyly type E2, Brachydactyly type E2 |
| RS267606987 |
PTHLH
|
Health Risk |
Pathogenic |
Brachydactyly type E2, Brachydactyly type E2 |
| RS267606988 |
PTHLH
|
Health Risk |
Pathogenic |
Brachydactyly type E2, Brachydactyly type E2 |
| RS267606989 |
PTPN11
|
Health Risk |
Pathogenic |
Metachondromatosis, RASopathy |
| RS267606990 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 1, Noonan syndrome |
| RS267606991 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS267606992 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS267606993 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS267606995 |
RAB39B
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 72 |
| RS267606996 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS267606997 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS267606998 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS267606999 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS267607000 |
RBM10
|
Health Risk |
Pathogenic |
TARP syndrome, TARP syndrome |
| RS267607001 |
RBM20
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS267607002 |
RBM20
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1DD, Primary dilated cardiomyopathy |
| RS267607003 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Primary dilated cardiomyopathy |
| RS267607004 |
RBM20
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1DD, Primary dilated cardiomyopathy |
| RS267607005 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS267607006 |
RDH5
|
Health Risk |
Pathogenic |
Fundus albipunctatus, autosomal recessive |